A report from TheBusinessResearchCompany shows that the anemia and other blood disorder drugs market is expected to grow to $29.37 billion at a CAGR of 10.5% through 2022.
The anemia and other blood disorder drugs market consists of sales of anemia and other blood disorder drugs and related services. Anemia and other blood disorder drugs that are used to stimulate red blood cell production or hemoglobin in the human body that includes Erythropoietin (Epoetin alpha), Ferrous Sulfate, Iron Dextran, Deferoxamine, Immunosuppressant, Bone marrow stimulants, Corticosteroids, Aminoxin, Hespan, Hextend and Pyridoxine. The market also comprises of sales of drugs that are responsible for curing other blood disorders, including inherited orphan blood disorder.
Explore Complete Report “Anemia And Other Blood Disorder Drugs Global Market Report 2019” at: https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report
The global anemia and other blood disorder drugs market was valued at about $19.7 billion in 2018 and is expected to grow to $29.37 billion at a CAGR of 10.5% through 2022.
North America was the largest region in the anemia and other blood disorder drugs market in 2018. The anemia and other blood disorder drugs market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.
Request to get the sample of this report: https://www.thebusinessresearchcompany.com/sample.aspx?id=2465&type=smp
Major Key competitive players in the global anemia and other blood disorder drugs market report include Amgen Inc., GlaxoSmithKline plc, Akebia therapeutics, Bayer AG and Pfizer Inc.
The increasing prevalence of anemia among the global population acts as a strong driving factor for the market. Unhealthy lifestyles, changing dietary habits and increased stress levels increased the cases of anemia worldwide. For instance, in the year 2017, anemia was found to be most frequent disease in elderly population (> 65 years of age), reaching a prevalence rate of around 17%. In 2014, the World Bank reported that anemia is the 8th leading cause of disease among the women and young population. Growth in prevalence rate of anemia drives the market.
Get Discount On This Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=2465&type=discount
Few Chapters from Table Of Content:
- Executive Summary
- Report Structure
- Anemia And Other Blood Disorder Drugs Market Characteristics
- Anemia And Other Blood Disorder Drugs Market Product Analysis
- Anemia And Other Blood Disorder Drugs Market Supply Chain
- Anemia And Other Blood Disorder Drugs Market Customer Information
- Anemia And Other Blood Disorder Drugs Market Trends And Strategies
- Anemia And Other Blood Disorder Drugs Market Size And Growth
- Anemia And Other Blood Disorder Drugs Market Regional Analysis
View similar report, Biologics Market Global Opportunities And Strategies Report 2021 at https://www.thebusinessresearchcompany.com/report/biologics-market
The biologics industry comprises companies manufacturing biological products. Biological products include a wide range of products such as vaccines, allergenics, somatic cells, tissues, and recombinant therapeutic proteins. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living entities such as cells and tissues.
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]